Isopropyl-β-d-1-thiogalactopyranoside (IPTG) and H2O2 were purchased from Wako Pure Chemical Industries (Osaka, Japan). The reduced form of GSH, 6-OHDA, catalase, and anti-β-actin (AC-15) was obtained from Sigma-Aldrich (St Louis, MO). A protease inhibitor cocktail tablet was obtained from Nacalai Tesque (Kyoto, Japan). Ni-nitrilotriacetic acid (NTA) agarose was purchased from QIAGEN GmbH (Hilden, Germany). Benzoquinone (BzQ) was purchased from Tokyo Chemical Industry (Tokyo, Japan). Dulbecco’s modified Eagle’s medium/Nutrient Mixture F-12 (DMEM/F-12, 11320-033) was obtained from Thermo Fisher Scientific (Waltham, MA), and fetal bovine serum (FBS, GPK0029) was purchased from HyClone (Logan, UT). SH-SY5Y cells were obtained from the American Tissue Type Collection (Manassas, VA). Other chemicals used were of the highest quality commercially available. Monoclonal antibodies against oxDJ-1 were prepared as previously described.18
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.